APP and Alzheimer disease: Thus, all known mutations that cause the early onset of AD augment the rate of accumulation of AβPP-derived iAβ, resulting in the earlier, accelerated crossing of the second-AD-stage-activating threshold, activation of the AβPP-independent iAβ production pathway, and commencement of the disease [4].